InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,283.48
(
-0.40%
)
US TECH 100
18,288.00
(
-0.16%
)
Dow Jones
38,734.08
(
-0.86%
)
Brent Oil
84.13
(
1.55%
)
Bitcoin
67,481.90
(
-2.76%
)
Post# of 251948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11495
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: biotech_researcher post# 213272

Sunday, 08/27/2017 10:19:26 AM

Sunday, August 27, 2017 10:19:26 AM

Post# of 251948
The NEJM had the full report this morning on Canakinumab this morning.

Their editorial basically said that while treating inflammation looks very interesting to explore, at $100k to $200K per year, it isn't going to the masses.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up